SEC Form 4 · accession 0001179110-17-012721

ABBOTT LABORATORIES · ABT

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Senior Vice President

Period of report

Sep 22, 2017

Accepted (ET)

Sep 26, 2017 · 5:47 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000001800

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common shares without par value	Sep 22, 2017	M	13,400	$26.1879	A	58,739	D
Common shares without par value	Sep 22, 2017	M	17,300	$22.3919	A	76,039	D
Common shares without par value	Sep 22, 2017	M	22,000	$27.0336	A	98,039	D
Common shares without par value	Sep 22, 2017	S	34,400	$51.95	D	63,639	D
Common shares without par value	Sep 22, 2017	S	4,152	$51.96	D	59,487	D
Common shares without par value	Sep 22, 2017	S	1,701	$51.97	D	57,786	D
Common shares without par value	Sep 22, 2017	S	1,913	$51.98	D	55,873	D
Common shares without par value	Sep 22, 2017	S	909	$51.99	D	54,964	D
Common shares without par value	Sep 22, 2017	S	1,109	$52.00	D	53,855	D
Common shares without par value	Sep 22, 2017	S	3,816	$52.01	D	50,039	D
Common shares without par value	Sep 22, 2017	S	1,600	$52.02	D	48,439	D
Common shares without par value	Sep 22, 2017	S	200	$52.025	D	48,239	D
Common shares without par value	Sep 22, 2017	S	500	$52.03	D	47,739	D
Common shares without par value	Sep 22, 2017	S	1,200	$52.04	D	46,539	D
Common shares without par value	Sep 22, 2017	S	1,200	$52.041	D	45,339	D
Common shares without par value^F1	holding	—	—		—	21	I	Profit Sharing Trust
Common shares without par value^F2	holding	—	—		—	64,297	I	Jaime Contreras Marvan 2006 Living Trust
Common shares without par value^F3	holding	—	—		—	2,410	I	By Spouse
Common shares without par value^F4	holding	—	—		—	12,081	I	Living Trust (by spouse)

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	D/I
Option (right to buy)^F5	$26.1879	Sep 22, 2017	M	13,400	D	Feb 19, 2013	Feb 18, 2020	Common shares	13,400	D
Option (right to buy)^F5	$22.3919	Sep 22, 2017	M	17,300	D	Feb 18, 2014	Feb 17, 2021	Common shares	17,300	D
Option (right to buy)^F5	$27.0336	Sep 22, 2017	M	22,000	D	Feb 17, 2015	Feb 16, 2022	Common shares	22,000	D

F1Balance in the Abbott Laboratories Stock Retirement Trust as of September 22, 2017.
F2Held in the Jaime Contreras Marvan 2006 Living Trust. The reporting person is sole trustee of the trust. The trust is revocable.
F3The reporting person disclaims beneficial ownership of all securities held by his spouse.
F4Held in spouse's living trust. The reporting person's spouse is sole trustee of the trust. The trust is revocable. The reporting person disclaims beneficial ownership of these securities.
F5Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.

These transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c).